Constructive Bio, the pioneering synthetic genomics company, today announced that it has secured $58 million in the first close of its Series A financing, bringing the total amount raised by the company to date to $75 million. The round was led by Ahren, OMX Ventures and Paladin Capital Group with participation from Fine Structure Ventures, +ND Capital and Abcam-founder Jonathan Milner. Source: Constructive Bio press release 24/9/24